Literature DB >> 11341181

[Histoacryl vs Dermabond cyanoacrylate glue for closing small operative wounds].

Z Steiner1, J Mogilner.   

Abstract

Acrylate glues used in a childrens' day care unit to close small surgical wounds were compared. In 157 children, aged 12 weeks to 3.7 years, either Histoacryl or Dermabond was used (respectively, H: Ethicon Inc., Johnson & Johnson, NJ or D: Dermabond, Braun Surgical Gmbh, Melsungen, Germany). Operations were for inguinal hernia (110 cases), hydrocele (25), undescended testis (16), umbilical hernia (13) and funiculocele (3). 1 week after surgery the wounds were evaluated in terms of integrity of closure, redness or infection, need for antibiotics, wound granuloma, and parental satisfaction with instructions and actual method of wound caring. 3 months after surgery the wound/scar was reexamined. The margins of the wounds were separated partially or completely in 8 of 85 in group H (9.4%) while in the D group, 2 wounds (2.4%) had partially opened (p < 0.05). There were no differences between the glues with regard to wound infection or cosmetic results. Parental satisfaction was higher with D (96%) than H (82%) but the difference was not statistically significant. It is convenient to use glue to close operative wounds in children after ambulatory surgery. The use of D significantly reduced wound ruptures compared to H. Long-term cosmetic results were similar.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11341181

Source DB:  PubMed          Journal:  Harefuah        ISSN: 0017-7768


  2 in total

1.  Successful endoscopic management of a persistent bronchobiliary fistula with Histoacryl®/Lipiodol® mixture.

Authors:  N Pinsker; M Papoulas; M Sodergren; P Harrison; N Heaton; K Menon
Journal:  Ann R Coll Surg Engl       Date:  2018-03-15       Impact factor: 1.891

2.  A randomized, controlled study comparing two standardized closure methods of laparoscopic port sites.

Authors:  Kai Chen; Allan S Klapper; Hayley Voige; Giuseppe Del Priore
Journal:  JSLS       Date:  2010 Jul-Sep       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.